Join this webinar, hosted by Central and South Genomics and the North Thames Genomics Laboratory Hub, to learn more about rapid testing for foetal anomalies.

The R21 educational MDTs are co-ordinated by the two laboratories that provide this testing (Central and South Genomic Laboratory Hub (GLH) and the North Thames GLH), and aim to:

• Engage nationally with clinical colleagues involved in the prenatal setting

• Promote the rapid foetal WES service to ensure all pregnancies / couples eligible have the opportunity to access testing, and to update on any changes
• Provide content to increase knowledge of genomic testing, analysis and results

The Genomic Medicine Service (GMS) provides the national genomic testing for rare disease and cancer within NHS England by delivery of the National Genomic Test Directory.

Rapid testing for foetal anomalies with a likely monogenic disorder (R21) is an indication within the National Genomic Test Directory; rapid exome sequencing is performed for a nationally agreed panel of genes known to cause disorders which may present prenatally with fetal structural anomalies.

Please note that the MDTs are for NHS staff only. Meeting invite should not be forwarded to colleagues from commercial entities without prior agreement with NHSE.